The global minimally invasive neurosurgical devices market is projected to reach $4.32 billion by 2030.
The market is projected to grow from $3.04 billion in 2025 to $3.27 billion in 2026, representing a compound annual growth rate of 7.6%. Through 2030, the market is expected to grow at a CAGR of 7.2%, according to an Aug.18 news release.
The report identified AI-powered surgical navigation tools, robotic-assisted neurosurgery systems, minimally invasive spinal surgeries, real-time intraoperative imaging and expansion of ASCs among factors expected to drive growth.
North America was the largest market for minimally invasive neurosurgical devices in 2025. Asia-Pacific is expected to be the fastest-growing market during the forecast period.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
